{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:30:48Z","timestamp":1790011848083,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["EFOP-3.6.3-VEKOP-16-2017-00009"],"award-info":[{"award-number":["EFOP-3.6.3-VEKOP-16-2017-00009"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["EFOP-3.6.3-VEKOP-16-2017-00009"],"award-info":[{"award-number":["EFOP-3.6.3-VEKOP-16-2017-00009"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI050484"],"award-info":[{"award-number":["R01-AI050484"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI124429"],"award-info":[{"award-number":["R01-AI124429"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI084860"],"award-info":[{"award-number":["R01-AI084860"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI050484"],"award-info":[{"award-number":["R01-AI050484"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI124429"],"award-info":[{"award-number":["R01-AI124429"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI084860"],"award-info":[{"award-number":["R01-AI084860"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI146101"],"award-info":[{"award-number":["R01-AI146101"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lack or dysfunction of the lymphatics leads to secondary lymphedema formation that seriously reduces the function of the affected organs and results in degradation of quality of life. Currently, there is no definitive treatment option for lymphedema. Here, we utilized nucleoside-modified mRNA encapsulated in lipid nanoparticles (LNPs) encoding murine Vascular Endothelial Growth Factor C (VEGFC) to stimulate lymphatic growth and function and reduce experimental lymphedema in mouse models. We demonstrated that administration of a single low-dose of VEGFC mRNA-LNPs induced durable, organ-specific lymphatic growth and formation of a functional lymphatic network. Importantly, VEGFC mRNA-LNP treatment reversed experimental lymphedema by restoring lymphatic function without inducing any obvious adverse events. Collectively, we present a novel application of the nucleoside-modified mRNA-LNP platform, describe a model for identifying the organ-specific physiological and pathophysiological roles of the lymphatics, and propose an efficient and safe treatment option that may serve as a novel therapeutic tool to reduce lymphedema.<\/jats:p>","DOI":"10.1038\/s41467-021-23546-6","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T10:07:47Z","timestamp":1623146867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1095-3425","authenticated-orcid":false,"given":"D\u00e1niel","family":"Sz\u0151ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6279-5131","authenticated-orcid":false,"given":"G\u00e1bor","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Kemecsei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3142-4071","authenticated-orcid":false,"given":"L\u00e1szl\u00f3","family":"B\u00e1lint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitti","family":"Szot\u00e1k-Ajtay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Aradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Styevk\u00f3n\u00e9 Dinny\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara L.","family":"Mui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying K.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1864-3851","authenticated-orcid":false,"given":"Katalin","family":"Karik\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu P.","family":"Kataru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak J.","family":"Mehrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6304-2369","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Jakus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"23546_CR1","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/nm.2545","volume":"17","author":"K Alitalo","year":"2011","unstructured":"Alitalo, K. The lymphatic vasculature in disease. Nat. Med. 17, 1371\u20131380 (2011).","journal-title":"Nat. Med."},{"key":"23546_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/CIRCRESAHA.115.306544","volume":"118","author":"A Aspelund","year":"2016","unstructured":"Aspelund, A., Robciuc, M. R., Karaman, S., Makinen, T. & Alitalo, K. Lymphatic system in cardiovascular medicine. Circ. Res. 118, 515\u2013530 (2016).","journal-title":"Circ. Res."},{"key":"23546_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nm.1960","volume":"15","author":"A Machnik","year":"2009","unstructured":"Machnik, A. et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat. Med. 15, 545\u2013552 (2009).","journal-title":"Nat. Med."},{"key":"23546_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1084\/jem.20132308","volume":"211","author":"Z Jakus","year":"2014","unstructured":"Jakus, Z. et al. Lymphatic function is required prenatally for lung inflation at birth. J. Exp. Med. 211, 815\u2013826 (2014).","journal-title":"J. Exp. Med."},{"key":"23546_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","volume":"560","author":"S Da Mesquita","year":"2018","unstructured":"Da Mesquita, S. et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease. Nature 560, 185\u2013191 (2018).","journal-title":"Nature"},{"key":"23546_CR6","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1172\/JCI63685","volume":"123","author":"C Martel","year":"2013","unstructured":"Martel, C. et al. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J. Clin. Invest. 123, 1571\u20131579 (2013).","journal-title":"J. Clin. Invest."},{"key":"23546_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.cmet.2013.04.002","volume":"17","author":"HY Lim","year":"2013","unstructured":"Lim, H. Y. et al. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. Cell Metab. 17, 671\u2013684 (2013).","journal-title":"Cell Metab."},{"key":"23546_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41586-019-1419-5","volume":"572","author":"JH Ahn","year":"2019","unstructured":"Ahn, J. H. et al. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature 572, 62\u201366 (2019).","journal-title":"Nature"},{"key":"23546_CR9","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.3389\/fimmu.2019.03043","volume":"10","author":"L Balint","year":"2019","unstructured":"Balint, L., Ocskay, Z., Deak, B. A., Aradi, P. & Jakus, Z. Lymph flow induces the postnatal formation of mature and functional meningeal lymphatic vessels. Front. Immunol. 10, 3043 (2019).","journal-title":"Front. Immunol."},{"key":"23546_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fbioe.2020.00136","volume":"8","author":"K Szotak-Ajtay","year":"2020","unstructured":"Szotak-Ajtay, K. et al. Reduced prenatal pulmonary lymphatic function is observed in Clp1 (K\/K) embryos with impaired motor functions including fetal breathing movements in preparation of the developing lung for inflation at birth. Front. Bioeng. Biotechnol. 8, 136 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"23546_CR11","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1172\/JCI71608","volume":"124","author":"PS Mortimer","year":"2014","unstructured":"Mortimer, P. S. & Rockson, S. G. New developments in clinical aspects of lymphatic disease. J. Clin. Invest. 124, 915\u2013921 (2014).","journal-title":"J. Clin. Invest."},{"key":"23546_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0002-9343(00)00727-0","volume":"110","author":"SG Rockson","year":"2001","unstructured":"Rockson, S. G. Lymphedema. Am. J. Med. 110, 288\u2013295 (2001).","journal-title":"Am. J. Med."},{"key":"23546_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio, T., Rye, S., Newman, B. & Hayes, S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 14, 500\u2013515 (2013).","journal-title":"Lancet Oncol."},{"key":"23546_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1196\/annals.1413.015","volume":"1131","author":"K Radhakrishnan","year":"2008","unstructured":"Radhakrishnan, K. & Rockson, S. G. The clinical spectrum of lymphatic disease. Ann. N. Y Acad. Sci. 1131, 155\u2013184 (2008).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"23546_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ni1013","volume":"5","author":"MJ Karkkainen","year":"2004","unstructured":"Karkkainen, M. J. et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5, 74\u201380 (2004).","journal-title":"Nat. Immunol."},{"key":"23546_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.20171868","volume":"215","author":"TV Petrova","year":"2018","unstructured":"Petrova, T. V. & Koh, G. Y. Organ-specific lymphatic vasculature: from development to pathophysiology. J. Exp. Med. 215, 35\u201349 (2018).","journal-title":"J. Exp. Med."},{"key":"23546_CR17","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.1093\/emboj\/20.17.4762","volume":"20","author":"T Makinen","year":"2001","unstructured":"Makinen, T. et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C\/D receptor VEGFR-3. EMBO J. 20, 4762\u20134773 (2001).","journal-title":"EMBO J."},{"key":"23546_CR18","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3109\/07388551.2015.1084266","volume":"36","author":"J Dumont","year":"2016","unstructured":"Dumont, J., Euwart, D., Mei, B., Estes, S. & Kshirsagar, R. Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives. Crit. Rev. Biotechnol. 36, 1110\u20131122 (2016).","journal-title":"Crit. Rev. Biotechnol."},{"key":"23546_CR19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/wrr.12063","volume":"21","author":"MA Hall","year":"2013","unstructured":"Hall, M. A., Robinson, H., Chan, W. & Sevick-Muraca, E. M. Detection of lymphangiogenesis by near-infrared fluorescence imaging and responses to VEGF-C during healing in a mouse full-dermis thickness wound model. Wound Repair Regen. 21, 604\u2013615 (2013).","journal-title":"Wound Repair Regen."},{"key":"23546_CR20","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1096\/fj.02-0401fje","volume":"16","author":"A Szuba","year":"2002","unstructured":"Szuba, A. et al. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 16, 1985\u20131987 (2002).","journal-title":"FASEB J."},{"key":"23546_CR21","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1161\/CIRCULATIONAHA.115.020143","volume":"133","author":"O Henri","year":"2016","unstructured":"Henri, O. et al. Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction. Circulation 133, 1484\u20131497 (2016). discussion 1497.","journal-title":"Circulation"},{"key":"23546_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/lrb.2009.0002","volume":"7","author":"DP Jin","year":"2009","unstructured":"Jin, D. P., An, A., Liu, J., Nakamura, K. & Rockson, S. G. Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: immunohistochemical and molecular characterization. Lymphat. Res. Biol. 7, 47\u201357 (2009).","journal-title":"Lymphat. Res. Biol."},{"key":"23546_CR23","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/nm1689","volume":"13","author":"T Tammela","year":"2007","unstructured":"Tammela, T. et al. Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat. Med. 13, 1458\u20131466 (2007).","journal-title":"Nat. Med."},{"key":"23546_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/CIRCULATIONAHA.110.965384","volume":"123","author":"M Lahteenvuo","year":"2011","unstructured":"Lahteenvuo, M. et al. Growth factor therapy and autologous lymph node transfer in lymphedema. Circulation 123, 613\u2013620 (2011).","journal-title":"Circulation"},{"key":"23546_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10456-015-9469-2","volume":"18","author":"MT Visuri","year":"2015","unstructured":"Visuri, M. T. et al. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study. Angiogenesis 18, 313\u2013326 (2015).","journal-title":"Angiogenesis"},{"key":"23546_CR26","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.107.704098","volume":"123","author":"C Norrmen","year":"2011","unstructured":"Norrmen, C., Tammela, T., Petrova, T. V. & Alitalo, K. Biological basis of therapeutic lymphangiogenesis. Circulation 123, 1335\u20131351 (2011).","journal-title":"Circulation"},{"key":"23546_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1161\/01.RES.88.6.623","volume":"88","author":"B Enholm","year":"2001","unstructured":"Enholm, B. et al. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ. Res. 88, 623\u2013629 (2001).","journal-title":"Circ. Res."},{"key":"23546_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1084\/jem.20020587","volume":"196","author":"A Saaristo","year":"2002","unstructured":"Saaristo, A. et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J. Exp. Med. 196, 719\u2013730 (2002).","journal-title":"J. Exp. Med."},{"key":"23546_CR29","doi-asserted-by":"publisher","first-page":"12677","DOI":"10.1073\/pnas.221449198","volume":"98","author":"MJ Karkkainen","year":"2001","unstructured":"Karkkainen, M. J. et al. A model for gene therapy of human hereditary lymphedema. Proc. Natl Acad. Sci. USA 98, 12677\u201312682 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"23546_CR30","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1096\/fj.04-1592fje","volume":"18","author":"A Saaristo","year":"2004","unstructured":"Saaristo, A. et al. Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds. FASEB J. 18, 1707\u20131709 (2004).","journal-title":"FASEB J."},{"key":"23546_CR31","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1172\/JCI83967","volume":"126","author":"HM Bui","year":"2016","unstructured":"Bui, H. M. et al. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD. J. Clin. Invest. 126, 2167\u20132180 (2016).","journal-title":"J. Clin. Invest."},{"key":"23546_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1234-4","volume":"15","author":"K Hollevoet","year":"2017","unstructured":"Hollevoet, K. & Declerck, P. J. State of play and clinical prospects of antibody gene transfer. J. Transl. Med. 15, 131 (2017).","journal-title":"J. Transl. Med."},{"key":"23546_CR33","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3389","volume":"47","author":"JC Nault","year":"2015","unstructured":"Nault, J. C. et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat. Genet. 47, 1187\u20131193 (2015).","journal-title":"Nat. Genet."},{"key":"23546_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines\u2014a new era in vaccinology. Nat. Rev. Drug Disco. 17, 261\u2013279 (2018).","journal-title":"Nat. Rev. Drug Disco."},{"key":"23546_CR35","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ymthe.2018.11.018","volume":"27","author":"A Magadum","year":"2019","unstructured":"Magadum, A., Kaur, K. & Zangi, L. mRNA-based protein replacement therapy for the heart. Mol. Ther. 27, 785\u2013793 (2019).","journal-title":"Mol. Ther."},{"key":"23546_CR36","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ymthe.2018.12.012","volume":"27","author":"Z Trepotec","year":"2019","unstructured":"Trepotec, Z., Lichtenegger, E., Plank, C., Aneja, M. K. & Rudolph, C. Delivery of mRNA therapeutics for the treatment of hepatic diseases. Mol. Ther. 27, 794\u2013802 (2019).","journal-title":"Mol. Ther."},{"key":"23546_CR37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ymthe.2019.02.019","volume":"27","author":"I Sahu","year":"2019","unstructured":"Sahu, I., Haque, A., Weidensee, B., Weinmann, P. & Kormann, M. S. D. Recent developments in mRNA-based protein supplementation therapy to target lung diseases. Mol. Ther. 27, 803\u2013823 (2019).","journal-title":"Mol. Ther."},{"key":"23546_CR38","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ymthe.2019.01.014","volume":"27","author":"HX Zhang","year":"2019","unstructured":"Zhang, H. X., Zhang, Y. & Yin, H. Genome editing with mRNA encoding ZFN, TALEN, and Cas9. Mol. Ther. 27, 735\u2013746 (2019).","journal-title":"Mol. Ther."},{"key":"23546_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","volume":"217","author":"N Pardi","year":"2015","unstructured":"Pardi, N. et al. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J. Control Release 217, 345\u2013351 (2015).","journal-title":"J. Control Release"},{"key":"23546_CR40","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"23546_CR41","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"23546_CR42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1182\/blood-2010-07-298562","volume":"117","author":"I Choi","year":"2011","unstructured":"Choi, I. et al. Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse. Blood 117, 362\u2013365 (2011).","journal-title":"Blood"},{"key":"23546_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","volume":"4","author":"CS Lee","year":"2017","unstructured":"Lee, C. S. et al. Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine. Genes Dis. 4, 43\u201363 (2017).","journal-title":"Genes Dis."},{"key":"23546_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14630","volume":"8","author":"N Pardi","year":"2017","unstructured":"Pardi, N. et al. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat. Commun. 8, 14630 (2017).","journal-title":"Nat. Commun."},{"key":"23546_CR45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10456-016-9505-x","volume":"19","author":"I Martinez-Corral","year":"2016","unstructured":"Martinez-Corral, I. et al. Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system. Angiogenesis 19, 433\u2013445 (2016).","journal-title":"Angiogenesis"},{"key":"23546_CR46","doi-asserted-by":"publisher","first-page":"e84095","DOI":"10.1172\/jci.insight.84095","volume":"1","author":"JC Gardenier","year":"2016","unstructured":"Gardenier, J. C. et al. Diphtheria toxin-mediated ablation of lymphatic endothelial cells results in progressive lymphedema. JCI Insight 1, e84095 (2016).","journal-title":"JCI Insight"},{"key":"23546_CR47","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1073\/pnas.92.8.3566","volume":"92","author":"A Kaipainen","year":"1995","unstructured":"Kaipainen, A. et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl Acad. Sci. USA 92, 3566\u20133570 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"23546_CR48","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","volume":"92","author":"TT Rissanen","year":"2003","unstructured":"Rissanen, T. T. et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ. Res. 92, 1098\u20131106 (2003).","journal-title":"Circ. Res."},{"key":"23546_CR49","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1089\/hum.2006.100","volume":"18","author":"I Kholova","year":"2007","unstructured":"Kholova, I. et al. Adenovirus-mediated gene transfer of human vascular endothelial growth factor-d induces transient angiogenic effects in mouse hind limb muscle. Hum. Gene Ther. 18, 232\u2013244 (2007).","journal-title":"Hum. Gene Ther."},{"key":"23546_CR50","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1096\/fj.01-1042com","volume":"16","author":"A Saaristo","year":"2002","unstructured":"Saaristo, A. et al. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J. 16, 1041\u20131049 (2002).","journal-title":"FASEB J."},{"key":"23546_CR51","doi-asserted-by":"publisher","first-page":"14389","DOI":"10.1073\/pnas.95.24.14389","volume":"95","author":"Y Cao","year":"1998","unstructured":"Cao, Y. et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Natl Acad. Sci. USA 95, 14389\u201314394 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"23546_CR52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/84643","volume":"7","author":"M Skobe","year":"2001","unstructured":"Skobe, M. et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7, 192\u2013198 (2001).","journal-title":"Nat. Med."},{"key":"23546_CR53","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.2353\/ajpath.2006.051251","volume":"169","author":"A Saaristo","year":"2006","unstructured":"Saaristo, A. et al. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am. J. Pathol. 169, 1080\u20131087 (2006).","journal-title":"Am. J. Pathol."},{"key":"23546_CR54","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1161\/CIRCULATIONAHA.113.002779","volume":"129","author":"M Jeltsch","year":"2014","unstructured":"Jeltsch, M. et al. CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation. Circulation 129, 1962\u20131971 (2014).","journal-title":"Circulation"},{"key":"23546_CR55","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.bjps.2020.05.009","volume":"73","author":"P Hartiala","year":"2020","unstructured":"Hartiala, P. et al. Phase 1 Lymfactin() study: short-term safety of combined adenoviral VEGF-C and lymph node transfer treatment for upper extremity lymphedema. J. Plast. Reconstr. Aesthet. Surg. 73, 1612\u20131621 (2020).","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"23546_CR56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-62703-260-5_2","volume":"969","author":"N Pardi","year":"2013","unstructured":"Pardi, N., Muramatsu, H., Weissman, D. & Kariko, K. In vitro transcription of long RNA containing modified nucleosides. Methods Mol. Biol. 969, 29\u201342 (2013).","journal-title":"Methods Mol. Biol."},{"key":"23546_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-1-62703-260-5_3","volume":"969","author":"D Weissman","year":"2013","unstructured":"Weissman, D., Pardi, N., Muramatsu, H. & Kariko, K. HPLC purification of in vitro transcribed long RNA. Methods Mol. Biol. 969, 43\u201354 (2013).","journal-title":"Methods Mol. Biol."},{"key":"23546_CR58","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/mt.2013.124","volume":"21","author":"MA Maier","year":"2013","unstructured":"Maier, M. A. et al. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. Mol. Ther. 21, 1570\u20131578 (2013).","journal-title":"Mol. Ther."},{"key":"23546_CR59","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.1002\/anie.201203263","volume":"51","author":"M Jayaraman","year":"2012","unstructured":"Jayaraman, M. et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew. Chem. Int Ed. Engl. 51, 8529\u20138533 (2012).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"23546_CR60","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1084\/jem.20081859","volume":"206","author":"Z Jakus","year":"2009","unstructured":"Jakus, Z., Simon, E., Frommhold, D., Sperandio, M. & Mocsai, A. Critical role of phospholipase Cgamma2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis. J. Exp. Med. 206, 577\u2013593 (2009).","journal-title":"J. Exp. Med."},{"key":"23546_CR61","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1084\/jem.20132496","volume":"211","author":"M Kovacs","year":"2014","unstructured":"Kovacs, M. et al. The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment. J. Exp. Med. 211, 1993\u20132011 (2014).","journal-title":"J. Exp. Med."},{"key":"23546_CR62","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23546-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23546-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23546-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T12:40:19Z","timestamp":1669984819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23546-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["23546"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-23546-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"assertion":[{"value":"13 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In accordance with the University of Pennsylvania policies and procedures and our ethical obligations as researchers, we report that Katalin Karik\u00f3 and Drew Weissman are named on patents that describe the use of nucleoside-modified mRNA as a platform to deliver therapeutic proteins. Drew Weissman and Norbert Pardi are also named on a patent describing the use of modified mRNA in lipid nanoparticles. We have disclosed those interests fully to the University of Pennsylvania, and we have in place an approved plan for managing any potential conflicts arising from licensing of our patents. No competing interests from other authors have been reported.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3460"}}